A presentation of the Memorial Sloan Kettering Cancer Center experience with active surveillance over a long-term follow-up. Read the article here.
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance? A roundtable discussion. Read the article here.
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance? Read More »
Larry Goldenberg, MD demonstrated his support for using active surveillance in intermediate-risk prostate cancer. Read the article here.
Active Surveillance for Intermediate Risk Prostate Cancer Read More »
A recent article exploring how physicians who manage prostate cancer regularly think about active surveillance and how to discuss this with their patients. Read the article here.
How 48 doctors think about active surveillance Read More »
A presentation of work assessing the feasibility of implementing a diet-based intervention in men with prostate cancer. Watch the interview here.
Diet Intervention in Men on Active Surveillance for Prostate Cancer Read More »
A critical question for men with favorable intermediate-risk prostate cancer (based primarily on a Gleason score of 3 + 4 = 7) can often be, “How safe would it be for me to go on active surveillance for a while after initial diagnosis?” Read the article here.
Active surveillance in men with Gleason 3 + 4 = 7 prostate cancer at diagnosis Read More »
A substantial proportion of men with low-risk prostate cancer can safely be followed with a de-intensified active surveillance protocol. Read the article here.
When can active surveillance be less active? Read More »
Predicting outcomes on active surveillance for intermediate-risk patients Read the article here. Active Surveillance for Intermediate-risk Prostate Cancer Challenged Read the article here. Active Surveillance versus Watchful Waiting Read the article here. Surgery isn’t necessarily best for prostate cancer, according to study led by Minneapolis VA Read the article here.
Active Surveillance Read More »
From a conference in May 2017, a comprehensive overview of active surveillance by one of the experts in the field. View video.
Video: Active Surveillance: Protecting Patients from Harm – Dr. Laurence Klotz Read More »
Younger age at diagnosis of low-risk prostate cancer was independently associated with decreased risk of disease progression in men managed with active surveillance, researchers reported. Read the article here. Active surveillance is a reasonable option for carefully selected men under 60 with low-risk prostate cancer. However, patients must be surveyed closely and understand the significant risk of ultimately needing treatment. Read the article here.
Active Surveillance in Men under 60 Read More »